Published • loading... • Updated
Atrial Fibrillation After Coronary Intervention: Shorter Antithrombotic Therapy May Be Beneficial
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Osaka – People with atrial fibrillation may benefit more from a one-month course of dual antithrombotic therapy after percutaneous coronary intervention (PCI) than from a twelve-month course. This is suggested by the multicenter, randomized "OPTIMA-AF" trial conducted by a Japanese research group (Lancet 2026; DOI: 10.1016/S0140-6736(26)00665-3). [The text abruptly ends here.]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
